Published in PLoS One on December 11, 2014
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol (2016) 0.98
The role of genomics in common variable immunodeficiency disorders. Clin Exp Immunol (2017) 0.79
Diagnostics of Primary Immunodeficiencies through Next-Generation Sequencing. Front Immunol (2016) 0.79
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med (2015) 0.76
Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome? Front Pediatr (2017) 0.75
Comprehensive genetic testing for primary immunodeficiency disorders in a tertiary hospital: 10-year experience in Auckland, New Zealand. Allergy Asthma Clin Immunol (2016) 0.75
Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene. Clin Immunol (2015) 0.75
Precision Medicine for Continuing Phenotype Expansion of Human Genetic Diseases. Biomed Res Int (2015) 0.75
FOXN1 deficient nude severe combined immunodeficiency. Orphanet J Rare Dis (2017) 0.75
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol (2005) 4.44
Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments. Nucleic Acids Res (2005) 3.59
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2014) 2.61
Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat (2010) 2.60
Next-generation sequencing: ready for the clinics? Clin Genet (2012) 1.75
Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel. PLoS One (2013) 1.51
PieceMaker: selection of DNA fragments for selector-guided multiplex amplification. Nucleic Acids Res (2005) 1.46
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev (2010) 1.37
Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories. Hum Mutat (2013) 1.32
Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol (2013) 1.28
Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol (2014) 1.26
ProbeMaker: an extensible framework for design of sets of oligonucleotide probes. BMC Bioinformatics (2005) 1.23
Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol (2014) 1.13
Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol (2009) 1.10
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing. Genet Med (2013) 1.09
RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks. Proc Natl Acad Sci U S A (2013) 1.00
PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet (2014) 0.94
Disperse--a software system for design of selector probes for exon resequencing applications. Bioinformatics (2009) 0.90
Primary immunodeficiency. Allergy Asthma Clin Immunol (2011) 0.86
DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome. Expert Rev Clin Immunol (2011) 0.84
Agammaglobulinemia: causative mutations and their implications for novel therapies. Expert Rev Clin Immunol (2013) 0.83
Setting up next-generation sequencing in the medical laboratory. Methods Mol Biol (2014) 0.80